Lipid MetabolismMarch 18, 20264 min read

Q-Bank Breakdown: Apolipoproteins — Why Every Answer Choice Matters

Clinical vignette on Apolipoproteins. Explain correct answer, then systematically address each distractor. Tag: Biochemistry > Lipid Metabolism.

Q-Bank Breakdown: Apolipoproteins — Why Every Answer Choice Matters

Tag: Biochemistry > Lipid Metabolism

Apolipoproteins are classic Step 1/2 “gotcha” territory because a single letter/number swap (ApoB-48 vs ApoB-100) can flip the entire diagnosis. The fastest way to master them is to treat every answer choice like a mini-teaching point—because in real q-banks, distractors are often nearly correct.

Clinical Vignette (Q-Bank Style)

A 34-year-old man presents with intermittent abdominal pain and recurrent episodes of pancreatitis. He has eruptive xanthomas on his extensor surfaces and lipemia retinalis on funduscopic exam. Labs show markedly elevated triglycerides with elevated chylomicrons even after fasting. Genetic testing reveals decreased activity of lipoprotein lipase.

Which apolipoprotein is required to activate the enzyme that is deficient in this patient?

A. ApoA-I
B. ApoB-48
C. ApoC-II ✅
D. ApoE
E. ApoB-100

Step-by-Step: Why the Correct Answer Is ApoC-II

✅ Correct Answer: ApoC-II

ApoC-II activates lipoprotein lipase (LPL), which hydrolyzes triglycerides in:

  • Chylomicrons
  • VLDL

Clinical tie-in (high yield):

  • LPL deficiency or ApoC-II deficiency → Type I hyperchylomicronemia
  • Findings: pancreatitis, eruptive xanthomas, lipemia retinalis
  • Typically no premature atherosclerosis (chylomicrons are too large to enter vessel walls easily)

Memory anchor:
C-II “Cuts” TGs via LPL

Distractor Breakdown: Why Each Wrong Answer Is Tempting (and How to Eliminate It)

A. ApoA-I — Wrong, but commonly confused

What it actually does:

  • Major apoprotein of HDL
  • Activates LCAT (lecithin-cholesterol acyltransferase) → esterifies cholesterol in HDL for reverse cholesterol transport

Associated disorders (high yield):

  • Tangier disease (ABCA1 defect) → very low HDL, orange tonsils, peripheral neuropathy
  • ApoA-I deficiency → low HDL, increased atherosclerosis risk

How to spot it on questions:

  • Anything involving HDL, reverse cholesterol transport, or LCAT → think ApoA-I

B. ApoB-48 — Wrong for LPL activation; right for chylomicron assembly

What it actually does:

  • Essential for chylomicron formation in intestinal mucosa
  • Produced in the intestine (edited version of ApoB mRNA)

Key associations:

  • Needed to package dietary TGs/cholesterol into chylomicrons
  • Doesn’t activate LPL; it’s more like the “structural scaffold”

High-yield comparison:

  • ApoB-48 = Begins in the Bowel (intestine)
  • ApoB-100 = made in liver, binds LDL receptor

D. ApoE — Wrong for enzyme activation; right for remnant uptake

What it actually does:

  • Mediates hepatic uptake of remnants via receptor binding:
    • Chylomicron remnants
    • IDL
  • Think: “E is for Endocytosis”

Classic board association:

  • Type III dysbetalipoproteinemia (ApoE mutation)
    • Elevated chylomicron remnants + IDL
    • Palmar xanthomas, premature atherosclerosis

How it differs from the stem:

  • Type III is about remnant clearance failure, not LPL hydrolysis failure
  • Often cholesterol and TG elevated, not isolated massive TG with fasting chylomicrons

E. ApoB-100 — Wrong for LPL activation; right for LDL receptor binding

What it actually does:

  • Structural apoprotein on:
    • VLDL
    • IDL
    • LDL
  • Binds LDL receptor (important for LDL uptake by cells)

Classic board association:

  • Familial hypercholesterolemia (LDL receptor defect or ApoB-100 defect)
    • Elevated LDL
    • Tendon xanthomas, corneal arcus
    • Premature atherosclerotic disease
    • TGs are not typically sky-high enough to cause pancreatitis

High-Yield Apolipoprotein Table (USMLE Essentials)

ApolipoproteinMain Lipoprotein(s)Core FunctionKeyword Association
ApoA-IHDLActivates LCATReverse cholesterol transport
ApoB-48ChylomicronsAssembly/structureIntestine-made
ApoB-100VLDL, IDL, LDLBinds LDL receptorLiver-made
ApoC-IIChylomicrons, VLDLActivates LPLTG hydrolysis
ApoEChylomicrons, VLDL remnants, IDLRemnant uptakeEndocytosis/Type III

Test-Day Pattern Recognition (What the Vignette Is Really Saying)

When you see:

  • Pancreatitis + eruptive xanthomas + lipemia retinalis
  • Very high triglycerides
  • Chylomicrons persist even after fasting

Think:

  • Type I hyperchylomicronemia
  • Due to LPL deficiency or ApoC-II deficiency
  • The apoprotein that activates the deficient enzyme = ApoC-II

Rapid-Fire USMLE Pearls

  • Pancreatitis risk rises significantly when TGs are > 1000 mg/dL.
  • Chylomicrons are dietary TG carriers; if they persist fasting → clearance problem (LPL/ApoC-II).
  • Atherosclerosis risk is strongest with LDL elevation (ApoB-100/LDL receptor problems), not isolated chylomicron excess.
  • ApoE problems → remnant accumulation → atherosclerosis + palmar xanthomas.

Mini Drill: One-Liners to Lock It In

  • ApoC-II: “turns on” LPL to unload triglycerides into tissues.
  • ApoE: tells the liver “take these remnants back.”
  • ApoB-48: builds chylomicrons in the intestine.
  • ApoB-100: gets LDL into cells via LDL receptor binding.
  • ApoA-I: activates LCAT on HDL for reverse cholesterol transport.
Back to all articles